Management
|
Targanta has built a strong senior management team led by
Pierre Etienne, M.D., the Company�s Chief Executive
Officer. Dr. Etienne joined Targanta in June 2003 after 14 years at Pfizer in
Groton, Connecticut, where he served in key executive positions in early clinical
research and development operations. The Company�s Chief Scientific Officer is
Thomas R. Parr, Jr. Ph.D. Dr. Parr has participated
in and led teams in both the discovery and the development of novel anti-infectives,
including work on beta-lactams, macrolides, lipopeptides, glycopeptides, protegrins,
echinocandins and adaptides. He has both academic and industrial experience. The
company�s Vice President of Finance, Christian Belisle,
has over 22 years of industry experience. Targanta�s management, its expertise
in pre-clinical and clinical matters, and its extensive network of well informed
contacts give the Company a competitive edge in licensing activities.
|